查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床試驗的全球市場:各階段，各疾病，各地區-預測及分析(2022年～2028年)
市場調查報告書
商品編碼
1165269

臨床試驗的全球市場:各階段，各疾病，各地區-預測及分析(2022年～2028年)

Global Clinical Trials Market, By Phase, By Disease & By Region- Forecast and Analysis 2022-2028
出版日期: | 出版商: SkyQuest | 英文 127 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球臨床試驗的市場規模從2021年的480億7,000萬美元，預計2028年達到805億3,000萬美元，從2022年到2028年的預測期間內的年複合成長率成為5.9％。對各種癌症的適應症作為對象的臨床試驗增加，癌症領域的藥物組合的研究開發預算，促進市場成長。

本報告提供全球臨床試驗市場相關調查分析，市場概要，市場規模，市場動態，企業簡介等系統性資訊。

目錄

摘要整理

市場概要

  • 資料:摘要整理-市場概要的圖
  • 資料:摘要整理-市場概要的資料表
  • 資料:摘要整理-全球臨床試驗市場特徵相關圖
  • 資料:摘要整理-市場地區:各地區
  • 資料:摘要整理-市場區隔的圖
  • 資料:摘要整理-增量成長的圖
  • 資料:摘要整理-增量成長相關資料表
  • 資料:摘要整理-供應商市場定位相關圖

親市場分析

市場概要

市場規模

  • 市場動態
    • 資料:DROC的影響分析(2021年)
  • 促進因素
  • 機會
  • 阻礙因素
  • 課題
  • SWOT分析

主要的市場洞察

  • 技術分析
    • (資料:資料表:技術名和詳細內容)
  • 價格分析
    • (資料:資料表:技術名和價格詳細內容)
  • 供應鏈分析
    • (資料:詳細的供應鏈簡報)
  • 價值鏈分析
    • (資料:詳細的價值鏈簡報)
  • 市場生態系統
    • 資料:親市場生態系統的市場分析
    • 圖表:父母市場市場特徵
  • IP分析
    • (資料:資料表:產品、技術名，申請專利，發明者、企業名，取得企業)
  • 貿易分析
    • (資料:資料表:進出口資料詳細內容)
  • Start-Ups分析
    • (資料:資料表:新興Start-Ups詳細內容)
  • 原料分析
    • (資料:資料表:主要原料的製圖)
  • 革新矩陣
    • (資料:定位矩陣:新技術與現有技術的製圖)
  • 開發中產品分析
    • (資料:資料表:企業名和開發中產品，各地區製圖)
  • 宏觀經濟指標

新型冠狀病毒的影響

  • 簡介
  • 經濟情境評估的影響
    • 資料:GDP相關資料-與前一年同期比較成長率(%)(2016年～2022年)
  • 被修正的市場規模
    • 資料:世界的臨床試驗市場規模與預測資料表(100萬美元)(2022年～2028年)
  • COVID對主要市場區隔的影響
    • 資料:市場區隔的市場規模與預測資料表(100萬美元)(2022年～2028年)
  • COVID策略:各企業
    • 資料:企業採用的主要的策略相關分析

市場動態與展望

  • 市場動態
    • 資料:DROC的影響分析(2021年)
  • 促進因素
  • 機會
  • 阻礙因素
  • 課題
  • 法規情形
    • 資料:不同的地區的法規相關資料表
  • SWOT分析
  • 波特五力分析
    • 競爭企業間的敵對關係
  • 圖表:競爭企業間的敵對關係，主要要素的影響(2021年)
    • 替代品的威脅
  • 圖表:替代品的威脅，主要要素的影響(2021年)
    • 買方議價能力
  • 圖表:買方議價能力，主要要素的影響(2021年)
    • 新加入業者的威脅
  • 圖表:新加入業者的威脅，主要要素的影響(2021年)
    • 供給企業談判力
  • 圖表:供給企業談判力，主要要素的影響(2021年)
  • 未來的混亂相關Skyquest的特別的洞察
    • 政治影響
    • 經濟影響
    • 社會影響
    • 技術性影響
    • 環境的影響
    • 法律上的影響
  • 全球臨床試驗市場:各階段
  • 全球臨床試驗市場:各疾病

市場規模:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 南美
    • 巴西
    • 其他南美
  • 中東及非洲(MEA)
    • GCC各國
    • 南非
    • 其他中東及非洲

主要企業簡介

  • 競爭情形
  • 資料:調查對象企業(2021年)
  • 資料:企業定位矩陣(2021年)
  • 資料:企業的市場佔有率，圓形圖表分析(%)(2021年)
簡介目錄
Product Code: SQSG35A2088

Global Clinical Trials Market was valued at US$ 48.07 billion in 2021, and it is expected to reach a value of US$ 80.53 billion by 2028, at a CAGR of more than 5.9% over the forecast period (2022- 2028).

Clinical trials are a method of conducting clinical research that is governed by a detailed protocol that has been carefully created to address a specific patient care question. Five phases can be used to categorize clinical trials, each of which serves a specific function. Every trial follows a protocol that specifies which people may take part in the study.

Along with describing the duration of the study, trials also detail the precise order of steps, tests, medications, and doses within the study. Since the costs of developing new drugs have significantly increased in recent years, pharma and biotech companies have been searching for modernizations and more efficient ways to run their operations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. 

Segments covered in this report:

Global Clinical trials Market is segmented based on the phase, disease and region. Based on Phases global clinical trials market is segmented into Phase I, Phase II, Phase III, Phase IV. Based on diseases the global clinical trials market is segmented into Autoimmune/Inflammation, Pain management, Oncology, CNS condition, Diabetes, Obesity, Cardiovascular, Others. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

About 30% of all trials were clinical trials for various oncology indications, which also happens to be the therapeutic area with the most drug launches. The majority of the top industry clinical trial sponsors dedicated a sizeable portion of their R&D budget to the oncology drug portfolio.

Non-small cell lung cancer (NSCLC) and breast cancer were primarily targeted for clinical development among the various oncology indications. However, the oncology clinical trial market is steadily becoming more complicated in terms of patient recruitment, clinical trial design elements like endpoints, and more stringent eligibility requirements, among other things.

Restraint

The focus has shifted to genetic and rare diseases, making it difficult to find the right patient population. Additionally, the lack of patient knowledge about clinical trials creates a difficult environment for CROs. The scientific and financial viability could be impacted by improper patient recruitment. The Tufts Center for the Study of Drug Development reports that 11% of clinical trial sites in 2013 were unable to sign up even one patient.

Patient fear of side effects, illiteracy, language barriers for region-specific clinical trials, and documentation of the consent process are additional causes of low patient recruitment.

Market Trends

For businesses in the clinical trials market, the proliferation of digital innovations made possible by wearables and sensors is translating into value-grabbing opportunities. ICON plc, a company that conducts clinical research, is looking into how digital endpoints, such as digital biomarkers, can enhance trial outcomes. As a result, digital health technologies that facilitate sensible device selection and data strategies have been adopted.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global Clinical Trials Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Global Clinical Trials Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Global Clinical Trials Market by Phase

  • Market segments
    • Exhibit: Chart on Market share 2021-2027 (%)
    • Exhibit: Data table on Market share 2021-2027 (%)
  • Phase I
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Phase II
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Phase III
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Phase IV
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

Global Global Clinical Trials Market by Disease

  • Market segments
    • Exhibit: Chart on Market share 2021-2027 (%)
    • Exhibit: Data table on Market share 2021-2027 (%)
  • Autoimmune/Inflammation
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Pain Management
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Oncology
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • CNS Condition
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Diabetes
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Obesity
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Cardiovascular
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)